John Passalacqua, CEO of First Phosphate Corp., increased his beneficial ownership by 420,000 common shares due to vesting of restricted share units on July 3, 2026. However, his overall stake fell below 10% on June 12, 2026, due to dilution from the company's private placement financing. After the private placement, he owned about 9.88% of the company on a partially diluted basis, which rose to approximately 9.99% following the recent share increase. This update complies with Canadian securities regulations and reflects ongoing changes in insider ownership.
The Québec Superior Court has approved a restructuring transaction for Premier Health of America Inc., allowing the company to continue uninterrupted operations. The deal involves the acquisition of three affiliates by Polar Valley Investments Limite...
Alvotech announced that Celtic Lux Holdings S.a. r.l., formerly Alvogen Lux Holdings, pledged 88,940,619 shares and 7,007,321 Swedish warrants equivalent to shares on June 26. This transaction was reported to Luxembourg's financial regulator CSSF. Th...
Canada's federal government and British Columbia have signed the Cooperative Prosperity Agreement, aiming to unlock over $200 billion in new investments focused on natural resources like LNG, critical minerals, and infrastructure. Concurrently, Alber...
Crédit Agricole has increased its ownership in Banco BPM to 29.3%, surpassing the 25% threshold through market purchases and derivatives. This move reflects Crédit Agricole's commitment as a long-term investor supporting the Italian economy and stren...
Appili Therapeutics announced that the National Institute of Allergy and Infectious Diseases (NIAID) has terminated its contract for the development of the VXV-01 fungal vaccine program. The contract, awarded in October 2025 with a base period of 22 ...
